Desmoid Fibromatosis
Information
- Disease name
- Desmoid Fibromatosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02834013 | Active, not recruiting | Phase 2 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | January 30, 2017 | May 1, 2026 |
| NCT04195399 | Active, not recruiting | Phase 2 | A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery | October 7, 2020 | December 31, 2024 |
| NCT03966742 | Completed | Phase 2 | Doxorubicin Eluting Intra-arterial Embolization for Aggressive Desmoid Fibromatosis | October 11, 2018 | December 18, 2020 |
| NCT02066181 | Completed | Phase 3 | Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis | March 21, 2014 | December 1, 2022 |
| NCT06355921 | Not yet recruiting | N/A | A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors | April 1, 2024 | May 1, 2028 |
| NCT02402244 | Recruiting | Project: Every Child for Younger Patients With Cancer | November 3, 2015 | December 31, 2030 | |
| NCT04281381 | Recruiting | Observing People With Desmoid-Type Fibromatosis | February 19, 2020 | February 19, 2025 |